Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Obstetrics/Gynecology Market Research

Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19

Best Price Guarantee Length Publisher Published Date SKU
from $2,490 250 Pages Renub Research April, 2022 RNBR17135998
Best Price Guarantee
Price from $2,490
Length 250 Pages
Publisher Renub Research
Published Date April, 2022
SKU RNBR17135998

Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19

Asia Cervical Cancer Test (Screening) Market will reach US$ 4.5 Billion by 2027. Cervical cancer is a type of cancer caused due to the rampant proliferation of the cell. In 2021, as per our Report Statistics, more than 100 Million populations were diagnosed with cervical cancer. In women, cervical cancer ranks as the 4th most frequent cancer in Asia-Pacific. This increasing prevalence of cervical cancer has increased the need for cervical cancer screening tests among women. Thus, cervical cancer screening detects precancerous or cancerous changes in the cervix. It has been advised that women over 30 years of age should undergo regular Pap tests, although this may vary based on risk factors and clinical practices. The goal of screening is to find precancerous changes in the cervix so that they can be treated before shifting into full-blown cancer. This early detection may stop women from dying from cervical cancer.

Factors Driving Asia Cervical Cancer Screening Industry

The fastest-growing cervical cancer screening tests in the Asia-Pacific market attribute its development to the rising prevalence of cervical cancer in developing Asian countries like Indonesia, China, India, Malaysia, Japan, Singapore, South Korea, and Thailand. Further, the growing women population, the ever-increasing sum of structured cervical cancer programs introduced by governments and international NGOs, and the inception of low-cost cervical cancer tests are significant growth drivers for the growth of the Asia cervical cancer screening market in developing countries. According to Renub Research Report, the Asia Cervical Cancer Test (Screening) Industry is expected to expand at a CAGR Of 3.79% during 2021-2027.

Asia Cervical Cancer Test (Screening) Market Size was US$ 3.6 Billion in 2021:

Based on type, Asia Cervical Cancer Test (Screening) market includes Pap Smear Market, HPV DNA Market, and VIA Market. Despite the declining women population, Japan has one of the significant market share in the Pap smear test market. The Pap smear test is the most useful tool for diagnosing HPV in Japanese hospitals and clinics, was the most revenue-generating segment. The Pap smear is a diagnostic procedure that helps Japanese doctors check for cervical cancer in women. It’s utilized to screen for precancerous cells on the cervix before they turn into full-blown cancer. Japanese doctors use these screening tests to find and treat irregular changes while there are still no signs of physical damage or disease – this can result in lower rates of death from cervical cancer later down the line.

Likewise, China dominates visual inspection with acetic acid (VIA) testing population. VIA (Visual Optical Inspection Using Acetic Acid) is a screening test that allows for the early detection of cervical cancer and precancerous lesions. This technique uses acetic acid, an active agent that turns the surface of the cervix white if abnormal cells or precancerous lesions are present on it. A woman places vinegar in her vagina and then has to lie down with her hips elevated to avoid losing any liquid inside.

COVID-19 Impact on Asia Cervical Cancer Test (Screening) Market:

In the COVID-19 pandemic, the number of screening tests was reduced to very low in Asia-Pacific. Lockdown has resulted in the devotion of a large number of non-urgent appointments. Things have started to move in the earlier two quarters, but the cancelation screening test numbers have not recovered to pre-COVID-19. During the attempts to deliver cervical cancer screening, preventive measures should be implemented as instructed by the health officers.

Renub Research report titled “Asia Cervical Cancer Test (Screening) Market by Type (Pap smear Market, HPV DNA Market, VIA (visual inspection with acetic acid) Market), by Countries (Indonesia, China, India, Malaysia, Japan, Singapore, South Korea, and Thailand)” provide complete detail on Asia Cervical Cancer Test (Screening) Industry.

Type - Market has been covered from 3 viewpoints:

1. Pap smear Market
2. HPV DNA Market
3. VIA (visual inspection with acetic acid) Market

Countries - Market have been covered from 8 viewpoints:

1. Japan
2. South Korea
3. Singapore
4. Malaysia
5. India
6. China
7. Thailand
8. Indonesia


1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Asia Cervical Cancer Test (Screening) Analysis
5.1 Asia Cervical Cancer Test Population
5.1.1 Pap smear Test Population
5.1.2 HPV DNA Test Population
5.1.3 VIA Test Population
5.2 Asia Cervical Cancer Test (Screening) Market
5.2.1 Pap Smear Test Market
5.2.2 HPV DNA Test Market
5.2.3 Visual Inspection with Acetic Acid (VIA) Test Market
6. Countries - Asia Cervical Cancer Test Market & Population Share Analysis
6.1 Asia Cervical Cancer Test Population Share
6.1.1 Pap Smear Population
6.1.2 HPV DNA Population
6.1.3 VIA Population
6.2 Asia Cervical Cancer Market Share
6.2.1 Pap Smear Market
6.2.2 HPV DNA Market
6.2.3 VIA Market
7. Japan – Cervical Cancer Test Analysis
7.1 Population - Cervical Cancer Test (Screening)
7.1.1 Pap smear Test Population
7.1.2 HPV DNA Test Population
7.2 Market – Cervical Cancer Test (Screening)
7.2.1 Pap Smear Test Market
7.2.2 HPV DNA Test Market
8. South Korea – Cervical Cancer Tests Analysis
8.1 Population – Cervical Cancer Test (Screening)
8.1.1 Pap Smear Test Population
8.1.2 HPV DNA Test Population
8.2 Market – Cervical Cancer Test (Screening)
8.2.1 Pap Smear Test Market
8.2.2 HPV DNA Test Market
9. Singapore – Cervical Cancer Tests Analysis
9.1 Population – Cervical Cancer Test (Screening)
9.1.1 Pap Smear Test Population
9.1.2 HPV DNA Test Population
9.2 Market – Cervical Cancer Test (Screening)
9.2.1 Pap Smear Test Market
9.2.2 HPV DNA Test Market
10. Malaysia – Cervical Cancer Test Analysis
10.1 Population – Cervical Cancer Test (Screening)
10.1.1 Pap Smear Test Population
10.1.2 HPV DNA Test Population
10.2 Market – Cervical Cancer Test (Screening)
10.3 Pap Smear Test Market
10.4 HPV DNA Test Market
11. India – Cervical Cancer Test Analysis
11.1 Population – Cervical Cancer Test (Screening)
11.1.1 Pap Smear Test Population
11.1.2 HPV DNA Test Population
11.1.3 VIA Test Population
11.2 Market – Cervical Cancer Test (Screening)
11.2.1 Pap Smear Test Market
11.2.2 HPV DNA Test Market
11.2.3 VIA Test Market
12. China – Cervical Cancer Test Analysis
12.1 Population – Cervical Cancer Test (Screening)
12.1.1 Pap Smear Test Population
12.1.2 HPV DNA Test Population
12.1.3 VIA Test Population
12.2 Market – Cervical Cancer Test (Screening)
12.2.1 Pap Smear Test Population
12.2.2 HPV DNA Test Population
12.2.3 VIA Test Market
13. Thailand – Cervical Cancer Test Analysis
13.1 Population – Cervical Cancer Test (Screening)
13.1.1 Pap Smear Test Population
13.1.2 VIA Test Population
13.2 Market – Cervical Cancer Test (Screening)
13.2.1 Pap Smear Test Market
13.2.2 VIA Test Market
14. Indonesia – Cervical Cancer Test Analysis
14.1 Population – Cervical Cancer Test (Screening)
14.1.1 Pap Smear Test Population
14.1.2 HPV DNA Test Population
14.1.3 VIA Test Population
14.1.4 Pap smear & VIA Test Population
14.2 Market – Cervical Cancer Test (Screening)
14.2.1 Pap smear Test Market
14.2.2 HPV DNA Test Market
14.2.3 VIA Test Market
14.2.4 Pap smear & VIA Test Market
List of Figures:
Figure-01: Asia – Cervical Cancer Test (Screening) Population Volume (Million), 2017 – 2021
Figure-02: Asia – Forecast for Cervical Cancer Test (Screening) Population Volume (Million), 2022 – 2027
Figure-03: Asia – Pap Smear Test Population Volume (Million), 2017 – 2021
Figure-04: Asia – Forecast for Pap Smear Test Population Volume (Million), 2022 – 2027
Figure-05: Asia – HPV DNA Test Population Volume (Million), 2017 – 2021
Figure-06: Asia – Forecast for HPV DNA Test Population Volume (Million), 2022 – 2027
Figure-07: Asia – VIA Test Population Volume (Million), 2017 – 2021
Figure-08: Asia – Forecast for VIA Test Population Volume (Million), 2022 – 2027
Figure-09: Asia – Cervical Cancer Test (Screening) Market (Million US$), 2017 – 2021
Figure-10: Asia – Forecast for Cervical Cancer Test (Screening) Market (Million US$), 2022 – 2027
Figure-11: Asia – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-12: Asia – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-13: Asia – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-14: Asia – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-15: Asia – VIA Test Market (Million US$), 2017 – 2021
Figure-16: Asia – Forecast for VIA Test Market (Million US$), 2022 – 2027
Figure-17: Japan – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-18: Japan – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-19: Japan – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-20: Japan – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-21: Japan – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-22: Japan – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-23: Japan – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-24: Japan – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-25: South Korea – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-26: South Korea – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-27: South Korea – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-28: South Korea – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-29: South Korea – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-30: South Korea – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-31: South Korea – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-32: South Korea – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-33: Singapore – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-34: Singapore – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-35: Singapore – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-36: Singapore – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-37: Singapore – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-38: Singapore – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-39: Singapore – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-40: Singapore – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-41: Malaysia – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-42: Malaysia – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-43: Malaysia – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-44: Malaysia – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-45: Malaysia – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-46: Malaysia – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-47: Malaysia – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-48: Malaysia – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-49: India – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-50: India – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-51: India – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-52: India – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-53: India – VIA Test Population Volume (Thousand), 2017 – 2021
Figure-54: India – Forecast for VIA Test Population Volume (Thousand), 2022 – 2027
Figure-55: India – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-56: India – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-57: India – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-58: India – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-59: India – VIA Test Market Market (Million US$), 2017 – 2021
Figure-60: India – Forecast forVIA Test Market Market (Million US$), 2022 – 2027
Figure-61: China – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-62: China – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-63: China – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-64: China – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-65: China – VIA Test Population Volume (Thousand), 2017 – 2021
Figure-66: China – Forecast for VIA Test Population Volume (Thousand), 2022 – 2027
Figure-67: China – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-68: China – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-69: China – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-70: China – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-71: China – VIA Test Market Market (Million US$), 2017 – 2021
Figure-72: China – Forecast forVIA Test Market Market (Million US$), 2022 – 2027
Figure-73: Thailand – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-74: Thailand – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-75: Thailand – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-76: Thailand – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-77: Thailand – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-78: Thailand – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-79: Thailand – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-80: Thailand – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-81: Indonesia – Pap Smear Test Population Volume (Thousand), 2017 – 2021
Figure-82: Indonesia – Forecast for Pap Smear Test Population Volume (Thousand), 2022 – 2027
Figure-83: Indonesia – HPV DNA Test Population Volume (Thousand), 2017 – 2021
Figure-84: Indonesia – Forecast for HPV DNA Test Population Volume (Thousand), 2022 – 2027
Figure-85: Indonesia – VIA Test Population Volume (Thousand), 2017 – 2021
Figure-86: Indonesia – Forecast for VIA Test Population Volume (Thousand), 2022 – 2027
Figure-87: Indonesia – Pap smear & VIA Test Population Volume (Thousand), 2017 – 2021
Figure-88: Indonesia – Forecast for Pap smear & VIA Test Population Volume (Thousand), 2022 – 2027
Figure-89: Indonesia – Pap Smear Test Market (Million US$), 2017 – 2021
Figure-90: Indonesia – Forecast for Pap Smear Test Market (Million US$), 2022 – 2027
Figure-91: Indonesia – HPV DNA Test Market (Million US$), 2017 – 2021
Figure-92: Indonesia – Forecast for HPV DNA Test Market (Million US$), 2022 – 2027
Figure-93: Indonesia – VIA Test Market (Million US$), 2017 – 2021
Figure-94: Indonesia – Forecast for VIA Test Market (Million US$), 2022 – 2027
Figure-95: Indonesia – Pap smear & VIA Test Market (Million US$), 2017 – 2021
Figure-96: Indonesia – Forecast for Pap smear & VIA Test Market (Million US$), 2022 – 2027
List of Tables:
Table-01: Asia – Cervical Cancer Test (Screening) Population Share (Percent), 2017 – 2021
Table-02: Asia – Forecast for Cervical Cancer Test (Screening) Population Share (Percent), 2022 – 2027
Table-03: Asia – Pap Smear Test Population Volume Share by Country (Percent), 2017 – 2021
Table-04: Asia – Forecast for Pap Smear Test Population Volume Share by Country (Percent), 2022 – 2027
Table-05: Asia – HPV DNA Test Population Volume Share by Country (Percent), 2017 – 2021
Table-06: Asia – Forecast for HPV DNA Test Population Volume Share by Country (Percent), 2022 – 2027
Table-07: Asia – VIA Test Population Volume Share by Country (Percent), 2017 – 2021
Table-08: Asia – Forecast for VIA Test Population Volume Share by Country (Percent), 2022 – 2027
Table-09: Asia – Cervical Cancer Test (Screening) Market Share (Percent), 2017 – 2021
Table-10: Asia – Forecast for Cervical Cancer Test (Screening) Market Share (Percent), 2022 – 2027
Table-11: Asia – Pap Smear Test Market Share by Country (Percent), 2017 – 2021
Table-12: Asia – Forecast for Pap Smear Test Market Share by Country (Percent), 2022 – 2027
Table-13: Asia – HPV DNA Test Market Share by Country (Percent), 2017 – 2021
Table-14: Asia – Forecast for HPV DNA Test Market Share by Country (Percent), 2022 – 2027
Table-15: Asia – VIA Test Market Share by Country (Percent), 2017 – 2021
Table-16: Asia – Forecast for VIA Test Market Share by Country (Percent), 2022 – 2027

$2,490
$3,490

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings